The contemporary landscape of neuropsychiatric therapeutics is defined by an ongoing quest for innovative, highly effective interventions capable of alleviating treatment-resistant affective disorders. Among these conditions, severe panic anxiety and debilitating panic disorders stand out as pervasive pathologies driven by autonomic hyperactivity, dysregulated amygdala reactivity, and persistent fear conditioning. While standard pharmaceutical mainstays such as […]